Immuneering (IMRX) Change in Acquisitions & Divestments (2022 - 2024)
Historic Change in Acquisitions & Divestments for Immuneering (IMRX) over the last 3 years, with Q4 2024 value amounting to $5.5 million.
- Immuneering's Change in Acquisitions & Divestments fell 7112.86% to $5.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $31.9 million, marking a year-over-year decrease of 3894.84%. This contributed to the annual value of $31.9 million for FY2024, which is 3894.84% down from last year.
- Immuneering's Change in Acquisitions & Divestments amounted to $5.5 million in Q4 2024, which was down 7112.86% from $5.0 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Change in Acquisitions & Divestments registered a high of $32.3 million during Q2 2022, and its lowest value of $5.0 million during Q3 2023.
- Its 3-year average for Change in Acquisitions & Divestments is $16.1 million, with a median of $19.0 million in 2023.
- Per our database at Business Quant, Immuneering's Change in Acquisitions & Divestments crashed by 7402.6% in 2023 and then surged by 1278.95% in 2024.
- Over the past 3 years, Immuneering's Change in Acquisitions & Divestments (Quarter) stood at $20.6 million in 2022, then dropped by 7.52% to $19.0 million in 2023, then plummeted by 71.13% to $5.5 million in 2024.
- Its last three reported values are $5.5 million in Q4 2024, $5.0 million for Q2 2024, and $21.4 million during Q1 2024.